cardiac hypertrophy_Fxyd1<tm1Atck>/Fxyd1<tm1Atck>

http://metadb.riken.jp/0001625I129S7SvEvBrdC57BL6Fxyd1tm1AtckFxyd1tm1AtckFxyd1tm1Atck

cardiac hypertrophy_Fxyd1<tm1Atck>/Fxyd1<tm1Atck>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• FXYD domain-containing ion transport regulator 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:1889273

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Fxyd1<tm1Atck>/Fxyd1<tm1Atck>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Fxyd1<tm1Atck>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• cardiac hypertrophy
  http://purl.obolibrary.org/obo/MP_0001625

文献

http://purl.org/net/cito/citesAsAuthority

• Li-Guo. Jia, et.al., Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice., American journal of physiology. Heart and circulatory physiology, 2005, 288
  http://rdf.ncbi.nlm.nih.gov/pubmed/15563542